If you or someone you love have been diagnosed with Parkinson's disease and are struggling with uncontrolled movements and rigidity ("freezing"), you know how complex the treatment process can be. That's why you may be interested in learning more about The Parkinson's Disease Study, a clinical research study that is being conducted.

Many clinical research studies, including this one, are designed to test investigational medications to determine if they are safe and effective. Participation in a clinical research study is always voluntary, and choosing not to participate will in no way affect the current medical care you are receiving.

The Parkinson's Disease Study offers patients an opportunity to potentially optimize their treatment. It is examining the safety and effectiveness of an investigational drug for the uncontrolled movements and rigidity caused by levodopa, the most commonly prescribed treatment for Parkinson's disease. The investigational drug attempts to block chemicals in the brain that can contribute to movement disorders.

Study participation provides (at no cost):
frequent study-related medical care and support for up to 18 weeks
potential access to study drug for up to 12 weeks
In addition, some patients may be eligible to participate in a 36-week follow-up study. Everyone who participates in the follow-up study will receive the investigational drug at no cost.

To learn more about The Parkinson's Disease Study and see whether you may be able to participate, please visit www.aCombinedEffort.com. Whether or not you decide to participate in this clinical study, please seek advice and support from healthcare professionals and learn more about the treatment options and assistance available to you.

Sincerely,
The Parkinson's Disease Study Team
www.aCombinedEffort.com